Cargando…
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
The emergence of Plasmodium falciparum (Pf) parasite strains tolerant of the artemisinin component and resistant to the other drug component in artemisinin combination therapies (ACTs) used for treatment now markedly complicates malaria control. Thus, development of new combination therapies are urg...
Autores principales: | Watson, Daniel J., Laing, Lizahn, Beteck, Richard M., Gibhard, Liezl, Haynes, Richard K., Wiesner, Lubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450014/ https://www.ncbi.nlm.nih.gov/pubmed/36091789 http://dx.doi.org/10.3389/fphar.2022.957690 |
Ejemplares similares
-
An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
por: Tanner, Lloyd, et al.
Publicado: (2019) -
Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether
por: Watson, Daniel J., et al.
Publicado: (2021) -
In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline-O-Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites
por: Ramseier, Jessica, et al.
Publicado: (2023) -
Assessment of the Activity of Decoquinate and Its Quinoline-O-Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts
por: Ramseier, Jessica, et al.
Publicado: (2021) -
Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model
por: Abay, Efrem T, et al.
Publicado: (2015)